Evidence map›Paper›PMID 23349484›Full record

ArticleDiabetes2013

Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction.

Piruthivi Sukumar, Hema Viswambharan, Helen Imrie, Richard M Cubbon, Nadira Yuldasheva, Matthew Gage, Stacey Galloway, Anna Skromna, Parkavi Kandavelu, Celio X Santos and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 137 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Piruthivi SukumarDivision of Cardiovascular and Diabetes Research, Multidisciplinary Cardiovascular Research Centre, University of Leeds, Leeds, UK
Hema Viswambharan
Helen Imrie
Richard M Cubbon
Nadira Yuldasheva
Matthew Gage
Stacey Galloway
Anna Skromna
Parkavi Kandavelu
Celio X Santos
V Kate Gatenby
Jessica Smith
David J Beech
Stephen B Wheatcroft
Keith M Channon
Ajay M Shah
Mark T Kearney
University of Leeds · GB

Funding

British Heart Foundation FS/12/80/29821British Heart Foundation PG/09/042/27518British Heart Foundation RG/08/011/25922British Heart Foundation RG/09/010/28087British Heart Foundation RG/12/5/29576Medical Research Council G0901203Wellcome Trust 090532
6 · The paper itself

Abstract

Insulin resistance is characterized by excessive endothelial cell generation of potentially cytotoxic concentrations of reactive oxygen species. We examined the role of NADPH oxidase (Nox) and specifically Nox2 isoform in superoxide generation in two complementary in vivo models of human insulin resistance (endothelial specific and whole body). Using three complementary methods to measure superoxide, we demonstrated higher levels of superoxide in insulin-resistant endothelial cells, which could be pharmacologically inhibited both acutely and chronically, using the Nox inhibitor gp91ds-tat. Similarly, insulin resistance-induced impairment of endothelial-mediated vasorelaxation could also be reversed using gp91ds-tat. siRNA-mediated knockdown of Nox2, which was specifically elevated in insulin-resistant endothelial cells, significantly reduced superoxide levels. Double transgenic mice with endothelial-specific insulin resistance and deletion of Nox2 showed reduced superoxide production and improved vascular function. This study identifies Nox2 as the central molecule in insulin resistance-mediated oxidative stress and vascular dysfunction. It also establishes pharmacological inhibition of Nox2 as a novel therapeutic target in insulin resistance-related vascular disease.

Indexed as

AcetylcholineAnimalsCells, CulturedChromatography, High Pressure LiquidEndothelial CellsImmunoblottingInsulin ResistanceMaleMembrane GlycoproteinsMiceMice, KnockoutNADPH Oxidase 2NADPH OxidasesPolymerase Chain ReactionVasodilator AgentsAcetylcholineCybb protein, mouseMembrane GlycoproteinsNADPH Oxidase 2NADPH OxidasesVasodilator Agents

Identifiers

PMID23349484
PMCPMC3661635
OpenAlexW2143699322

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.